167 related articles for article (PubMed ID: 21555764)
1. Effects of etravirine alone and with ritonavir-boosted protease inhibitors on the pharmacokinetics of dolutegravir.
Song I; Borland J; Min S; Lou Y; Chen S; Patel P; Wajima T; Piscitelli SC
Antimicrob Agents Chemother; 2011 Jul; 55(7):3517-21. PubMed ID: 21555764
[TBL] [Abstract][Full Text] [Related]
2. Effect of fosamprenavir-ritonavir on the pharmacokinetics of dolutegravir in healthy subjects.
Song I; Borland J; Chen S; Peppercorn A; Wajima T; Piscitelli SC
Antimicrob Agents Chemother; 2014 Nov; 58(11):6696-700. PubMed ID: 25155604
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and tolerability of the maturation inhibitor GSK3640254 coadministered with darunavir/ritonavir and/or etravirine in healthy adults.
Zhang Y; Joshi S; Yazdani P; Zhan J; Wen B; Bainbridge V; Ballesteros-Perez A; Gartland M; Lataillade M
Br J Clin Pharmacol; 2024 Jan; 90(1):274-285. PubMed ID: 37621050
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of elvitegravir and etravirine following coadministration of ritonavir-boosted elvitegravir and etravirine.
Ramanathan S; Kakuda TN; Mack R; West S; Kearney BP
Antivir Ther; 2008; 13(8):1011-7. PubMed ID: 19195326
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic interactions between the hepatitis C virus protease inhibitor boceprevir and ritonavir-boosted HIV-1 protease inhibitors atazanavir, darunavir, and lopinavir.
Hulskotte EG; Feng HP; Xuan F; van Zutven MG; Treitel MA; Hughes EA; O'Mara E; Youngberg SP; Wagner JA; Butterton JR
Clin Infect Dis; 2013 Mar; 56(5):718-26. PubMed ID: 23155151
[TBL] [Abstract][Full Text] [Related]
6. Effects of enzyme inducers efavirenz and tipranavir/ritonavir on the pharmacokinetics of the HIV integrase inhibitor dolutegravir.
Song I; Borland J; Chen S; Guta P; Lou Y; Wilfret D; Wajima T; Savina P; Peppercorn A; Castellino S; Wagner D; Hosking L; Mosteller M; Rubio JP; Piscitelli SC
Eur J Clin Pharmacol; 2014 Oct; 70(10):1173-9. PubMed ID: 25146692
[TBL] [Abstract][Full Text] [Related]
7. Effects of etravirine on the pharmacokinetics of the integrase inhibitor S/GSK1265744.
Ford SL; Gould E; Chen S; Lou Y; Dumont E; Spreen W; Piscitelli S
Antimicrob Agents Chemother; 2013 Jan; 57(1):277-80. PubMed ID: 23114768
[TBL] [Abstract][Full Text] [Related]
8. Effect of atazanavir and atazanavir/ritonavir on the pharmacokinetics of the next-generation HIV integrase inhibitor, S/GSK1349572.
Song I; Borland J; Chen S; Lou Y; Peppercorn A; Wajima T; Min S; Piscitelli SC
Br J Clin Pharmacol; 2011 Jul; 72(1):103-8. PubMed ID: 21342217
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of Once-Daily Darunavir/Ritonavir With and Without Etravirine in Human Immunodeficiency Virus-Infected Children, Adolescents, and Young Adults.
Larson KB; Cressey TR; Yogev R; Wiznia A; Hazra R; Jean-Philippe P; Graham B; Gonzalez A; Britto P; Carey VJ; Acosta EP;
J Pediatric Infect Dis Soc; 2016 Jun; 5(2):131-7. PubMed ID: 27199469
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of darunavir/ritonavir and TMC125 alone and coadministered in HIV-negative volunteers.
Schöller-Gyüre M; Kakuda TN; Sekar V; Woodfall B; De Smedt G; Lefebvre E; Peeters M; Hoetelmans RM
Antivir Ther; 2007; 12(5):789-96. PubMed ID: 17713162
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the pharmacokinetic interaction between eltrombopag and lopinavir-ritonavir in healthy adult subjects.
Wire MB; McLean HB; Pendry C; Theodore D; Park JW; Peng B
Antimicrob Agents Chemother; 2012 Jun; 56(6):2846-51. PubMed ID: 22391553
[TBL] [Abstract][Full Text] [Related]
12. Effect of carbamazepine on dolutegravir pharmacokinetics and dosing recommendation.
Song I; Weller S; Patel J; Borland J; Wynne B; Choukour M; Jerva F; Piscitelli S
Eur J Clin Pharmacol; 2016 Jun; 72(6):665-70. PubMed ID: 26898568
[TBL] [Abstract][Full Text] [Related]
13. Dose separation does not overcome the pharmacokinetic interaction between fosamprenavir and lopinavir/ritonavir.
Corbett AH; Patterson KB; Tien HC; Kalvass LA; Eron JJ; Ngo LT; Lim ML; Kashuba AD
Antimicrob Agents Chemother; 2006 Aug; 50(8):2756-61. PubMed ID: 16870769
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of darunavir/ritonavir and rifabutin coadministered in HIV-negative healthy volunteers.
Sekar V; Lavreys L; Van de Casteele T; Berckmans C; Spinosa-Guzman S; Vangeneugden T; De Pauw M; Hoetelmans R
Antimicrob Agents Chemother; 2010 Oct; 54(10):4440-5. PubMed ID: 20660678
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of pharmacokinetic interaction between cetirizine and ritonavir, an HIV-1 protease inhibitor, in healthy male volunteers.
Peytavin G; Gautran C; Otoul C; Cremieux AC; Moulaert B; Delatour F; Melac M; Strolin-Benedetti M; Farinotti R
Eur J Clin Pharmacol; 2005 Jun; 61(4):267-73. PubMed ID: 15889300
[TBL] [Abstract][Full Text] [Related]
16. Lack of pharmacokinetic interaction between rilpivirine and integrase inhibitors dolutegravir and GSK1265744.
Ford SL; Gould E; Chen S; Margolis D; Spreen W; Crauwels H; Piscitelli S
Antimicrob Agents Chemother; 2013 Nov; 57(11):5472-7. PubMed ID: 23979733
[TBL] [Abstract][Full Text] [Related]
17. Single- and multiple-dose pharmacokinetics of darunavir plus ritonavir and etravirine in semen and rectal tissue of HIV-negative men.
Brown KC; Patterson KB; Jennings SH; Malone SA; Shaheen NJ; Asher Prince HM; Spacek M; Cohen MS; Kashuba AD
J Acquir Immune Defic Syndr; 2012 Oct; 61(2):138-44. PubMed ID: 22614898
[TBL] [Abstract][Full Text] [Related]
18. Coadministration of lopinavir/ritonavir and phenytoin results in two-way drug interaction through cytochrome P-450 induction.
Lim ML; Min SS; Eron JJ; Bertz RJ; Robinson M; Gaedigk A; Kashuba AD
J Acquir Immune Defic Syndr; 2004 Aug; 36(5):1034-40. PubMed ID: 15247556
[TBL] [Abstract][Full Text] [Related]
19. The effect of lopinavir/ritonavir and darunavir/ritonavir on the HIV integrase inhibitor S/GSK1349572 in healthy participants.
Song I; Min SS; Borland J; Lou Y; Chen S; Patel P; Ishibashi T; Piscitelli SC
J Clin Pharmacol; 2011 Feb; 51(2):237-42. PubMed ID: 20489027
[TBL] [Abstract][Full Text] [Related]
20. Beneficial pharmacokinetic interaction between atazanavir and lopinavir/ritonavir.
Pham PA; Flexner C; Parsons T; Vasist L; Fuchs E; Carson K; Agarwala S; Barditch-Crovo P
J Acquir Immune Defic Syndr; 2007 Jun; 45(2):201-5. PubMed ID: 17414932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
